Sangani Hospitals (NSE:SANGANI) Research & Development: ₹ Mil (TTM As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

NSE:SANGANI Sangani Hospitals Ltd NSE:SANGANI
81 GF Score
Price ₹48.75
GF Value ₹303.41
Valuation Possible Value Trap
! 7 Warning Signs
View Full Analysis

What is Sangani Hospitals Research & Development?

Sangani Hospitals NSE:SANGANI -2.30% 81 Research & Development is ₹ Mil as of Mar. 2026. GuruFocus rates NSE:SANGANI with a GF Score™ of 81/100 and a GF Value™ of ₹303.41 (Possible Value Trap). The stock has 7 warning signs investors should review.

Research & Development is the aggregate amount of research and development expenses during the year. Sangani Hospitals's Research & Development for the six months ended in Mar. 2026 was ₹ Mil. Its Research & Development for the trailing twelve months (TTM) ended in Mar. 2026 was ₹ Mil.

Sangani Hospitals  (NSE:SANGANI) Research & Development Explanation

If competitive advantage is created by a patent or tech advantage, at some point it will disappear.

High R&D usually dictates high SG&A which threatens the competitive advantage.

Sangani Hospitals Research & Development Related Terms

Sangani Hospitals Research & Development Historical Data

* Premium members only.

The historical data trend for Sangani Hospitals's Research & Development can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Sangani Hospitals Research & Development Chart

Sangani Hospitals Annual Data
Trend Mar20 Mar21 Mar22 Mar23 Mar24 Mar25 Mar26
Research & Development
Get a 7-Day Free Trial - - - - -

Sangani Hospitals Semi-Annual Data
Sep23 Mar24 Sep24 Mar25 Sep25 Mar26
Research & Development Get a 7-Day Free Trial - - - - -
NSE:SANGANI
81GF Score
Sangani Hospitals Ltd NSE:SANGANI
Research & Development is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Sangani Hospitals Research & Development Calculation

This is the expense the company spent on research and development.

Research & Development for the trailing twelve months (TTM) ended in Mar. 2026 adds up the semi-annually data reported by the company within the most recent 12 months, which was ₹ Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Research & Development →
What does a Research & Development of ₹ Mil mean?
Sangani Hospitals (NSE:SANGANI) has a Research & Development of ₹ Mil as of Mar. 2026. Research and development expense is the total cost for research and development activities. View historical data on Sangani Hospitals and its competitors.
Is Sangani Hospitals' Research & Development too high?
Sangani Hospitals' current Research & Development is ₹ Mil. Overall, Sangani Hospitals has a GF Score™ of 81/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Sangani Hospitals' Research & Development compare to HCA and THC?
Sangani Hospitals' Research & Development of ₹ Mil can be compared against companies in the Healthcare Providers & Services industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Research & Development for a Healthcare Providers & Services company?
A good Research & Development depends on the Healthcare Providers & Services industry context. However, Research & Development should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Research & Development mean?
A high Research & Development can signal that a stock is expensive relative to its fundamentals. Research and development expense is the total cost for research and development activities. View historical data on Sangani Hospitals and its competitors. Sangani Hospitals's current Research & Development is ₹ Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Sangani Hospitals stock overvalued right now?
Based on GuruFocus' analysis, Sangani Hospitals (NSE:SANGANI) is currently considered Possible Value Trap. The stock's GF Value™ is ₹303.41, compared to a current price of ₹48.75 — trading 83.9% below its estimated fair value. The current Research & Development is ₹ Mil. Sangani Hospitals' overall GF Score™ is 81/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Research & Development calculated?
Research & Development is calculated from a company's financial statements. For Sangani Hospitals (NSE:SANGANI), the current Research & Development is ₹ Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Sangani Hospitals (NSE:SANGANI) Overvalued in 2026?

Based on GuruFocus' analysis, Sangani Hospitals stock appears to be undervalued. The current stock price of ₹48.75 is trading 83.9% below its estimated GF Value™ of ₹303.41. GuruFocus considers Sangani Hospitals to be Possible Value Trap.

Key valuation signals for NSE:SANGANI:

  • Research & Development: ₹ Mil
  • GF Value™: ₹303.41 vs. price of ₹48.75 (83.9% below fair value)
  • GF Score™: 81/100 with 7 warning signs

No single metric tells the full story. See the NSE:SANGANI stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Sangani Hospitals Business Description

Address Sainath Society, Opp. S. T., KSD T, Taluka Keshod, Junagadh, GJ, IND, 362220
Sangani Hospitals Ltd is a multi-specialty healthcare provider operating in the Keshod and Veraval regions of Gujarat. Its services predominantly include super specialty services, specialty services, and other support services. It also operates a pathology laboratory and medical store. Currently, it operates out of two hospitals i.e. Sangani Hospital at Keshod, Junagadh, Gujarat and Sangani Super Speciality Hospital, Veraval, Gujarat. The company operates in a single segment, which is Healthcare. The company operates departments and units, including General Medicine, ENT, Dialysis, Orthopedics, General Surgery, Urosurgery, Trauma, and Physiotherapy.
81GF Score

Get the complete analysis for NSE:SANGANI

Research & Development is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₹48.75
Price
₹303.41
GF Value